Anne F. Rositch, Ph.D.
Affiliations: | 2011 | Epidemiology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Google:
"Anne Rositch"Parents
Sign in to add mentor| Jennifer L. Smith | grad student | 2011 | UNC Chapel Hill | |
| (Human papillomavirus type competition and the associations between HPV types and future HPV acquisition in men.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Itanyi IU, Viglione C, Rositch AF, et al. (2023) Rapid implementation mapping to identify implementation determinants and strategies for cervical cancer control in Nigeria. Frontiers in Public Health. 11: 1228434 |
| Schiffman M, Mirabello L, Egemen D, et al. (2023) The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecologic Oncology. 174: 253-261 |
| Beavis AL, Meek K, Moran MB, et al. (2022) Exploring HPV vaccine hesitant parents' perspectives on decision-making and motivators for vaccination. Vaccine: X. 12: 100231 |
| Schneiter MK, Levinson K, Rositch AF, et al. (2022) Gynecologic oncology HPV vaccination practice patterns: Investigating practice barriers, knowledge gaps and opportunities for maximizing cervical cancer prevention. Gynecologic Oncology Reports. 40: 100952 |
| Lichter KE, Levinson K, Hammer A, et al. (2022) Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States. Gynecologic Oncology |
| Rositch AF, Levinson K, Suneja G, et al. (2021) Epidemiology of cervical adenocarcinoma and squamous cell carcinoma among women living with HIV compared to the general population in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Dilley S, Huh W, Blechter B, et al. (2021) It's time to re-evaluate cervical Cancer screening after age 65. Gynecologic Oncology |
| Beavis AL, Najjar O, Cheskin LJ, et al. (2020) Prevalence of endometrial cancer symptoms among overweight and obese women presenting to a multidisciplinary weight management center. Gynecologic Oncology Reports. 34: 100643 |
| Paul P, Hammer A, Rositch AF, et al. (2020) Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. The Journal of Infectious Diseases |
| Barrett BW, Paz-Soldan VA, Mendoza-Cervantes D, et al. (2020) Understanding Geospatial Factors Associated With Cervical Cancer Screening Uptake in Amazonian Peruvian Women. Jco Global Oncology. 6: 1237-1247 |